{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:26:15Z","timestamp":1726759575893},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.encep.2012.05.001","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T19:03:45Z","timestamp":1338923025000},"page":"257-265","source":"Crossref","is-referenced-by-count":2,"title":["As\u00e9napine dans le trouble bipolaire\u00a0: efficacit\u00e9, tol\u00e9rance et utilisation en pratique clinique"],"prefix":"10.1016","volume":"38","author":[{"given":"L.","family":"Samalin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tixeront","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.encep.2012.05.001_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","article-title":"Prevalence and burden of bipolar disorders in European countries","volume":"15","author":"Pini","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2012.05.001_bib0010","series-title":"Manic-depressive illness. Bipolar disorders and recurrent depression","author":"Goodwin","year":"2007"},{"issue":"4","key":"10.1016\/j.encep.2012.05.001_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2012.05.001_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009\u00a0on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"issue":"36\u00a0Suppl.","key":"10.1016\/j.encep.2012.05.001_bib0025","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0013-7006(10)70037-3","article-title":"Screening and management of bipolar disorders: results","volume":"4","author":"Llorca","year":"2010","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2012.05.001_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","article-title":"Clinical practice recommendations for bipolar disorder","volume":"439","author":"Malhi","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"3","key":"10.1016\/j.encep.2012.05.001_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"issue":"12","key":"10.1016\/j.encep.2012.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1742-1241.2009.02228.x","article-title":"Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic","volume":"63","author":"Citrome","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.encep.2012.05.001_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/11206700-000000000-00000","article-title":"Asenapine: a review of its use in the management of mania in adults with bipolar I disorder","volume":"25","author":"Chwieduk","year":"2011","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.encep.2012.05.001_bib0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: a novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2012.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.neuropharm.2011.08.026","article-title":"Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration","volume":"62","author":"Elsworth","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.encep.2012.05.001_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7\u00a0receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2012.05.001_bib0065","first-page":"483","article-title":"Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder","volume":"5","author":"Bishara","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1\u20132","key":"10.1016\/j.encep.2012.05.001_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"issue":"7","key":"10.1016\/j.encep.2012.05.001_bib0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.encep.2012.05.001_bib0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jad.2010.04.005","article-title":"Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study","volume":"126","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"issue":"8","key":"10.1016\/j.encep.2012.05.001_bib0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1399-5618.2009.00749.x","article-title":"Asenapine versus olanzapine in acute mania: a double-blind extension study","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.encep.2012.05.001_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31823f872f","article-title":"Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension","volume":"32","author":"Szegedi","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2012.05.001_bib0095","unstructured":"EMEA. Assessment report Sycrest. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_- _Public_assessment_report\/human\/001177\/WC500096898.pdf 2010."},{"key":"10.1016\/j.encep.2012.05.001_bib0100","unstructured":"Zhao J, Ha X, Szegedi A. Early improvement predicts later outcome in manic or mixed episodes associated with bipolar I disorder: post hoc analyses of asenapine studies Pittsburgh 9th International Conference on bipolar disorder; June 9\u201311 2011."},{"key":"10.1016\/j.encep.2012.05.001_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-244X-11-101","article-title":"Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials","volume":"11","author":"Szegedi","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2012.05.001_bib0110","unstructured":"Azorin J, Sapin C, Weiller E. Effect of asenapine on depressive and manic symtpoms in bipolar I patients with mixed episodes. 11th International Forum on Mood and Anxiety Disorders (IFMAD), Budapest, Hungary: 9\u201311\u00a0November 2011."},{"key":"10.1016\/j.encep.2012.05.001_bib0115","unstructured":"Sapin C, Corson H, Hansen K. The effect of Asenapine on health-related quality of life in patients with manic or mixed episodes associated with bipolar I disorder. 2nd International Congress on Neurobiology, Psychopharmacology & Treatment Guidance, 24\u201327\u00a0Nov 2011."},{"key":"10.1016\/j.encep.2012.05.001_bib0120","unstructured":"HAS. Avis de la commission de transparence 2\u00a0novembre. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2011-12\/sycrest_2-11-2011_avis_ct-11050.pdf, 2011"},{"key":"10.1016\/j.encep.2012.05.001_bib0125","series-title":"The Maudsley Prescribing Guidelines","author":"Taylor","year":"2009"},{"issue":"2","key":"10.1016\/j.encep.2012.05.001_bib0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.encep.2012.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1017\/S0033291709005455","article-title":"Second-generation antipsychotics for schizophrenia: can we resolve the conflict?","volume":"39","author":"Leucht","year":"2009","journal-title":"Psychol Med"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700612000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700612000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T01:20:44Z","timestamp":1542936044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700612000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0013700612000747"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2012.05.001","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}